FDA delays decision on Raptor's Procysbi

Raptor Pharmaceutical Corp. (NASDAQ:RPTP) said FDA extended the PDUFA date by three months for an NDA for the company's Procysbi ( RP103) to treat nephropathic cystinosis. The new date is April 30, 20...